RNF6
ring finger protein 6, the group of Ring finger proteins
Basic information
Region (hg38): 13:26132114-26222314
Links
Phenotypes
GenCC
Source:
- esophageal cancer (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (13 variants)
- not provided (6 variants)
- Esophageal squamous cell carcinoma, somatic (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF6 gene is commonly pathogenic or not.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | 2 | ||||
missense | 3 | 12 | 3 | 1 | 19 | |
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice variant | 1 | 1 | ||||
non coding | 0 | |||||
Total | 3 | 0 | 12 | 4 | 3 |
Variants in RNF6
This is a list of pathogenic ClinVar variants found in the RNF6 region.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-26214123-G-A | Inborn genetic diseases | Uncertain significance (Jun 12, 2023) | ||
13-26214167-C-T | Benign (Aug 15, 2018) | |||
13-26214183-C-T | Inborn genetic diseases | Uncertain significance (Jul 07, 2022) | ||
13-26214218-G-T | Inborn genetic diseases | Uncertain significance (Nov 30, 2021) | ||
13-26214257-G-T | Likely benign (Apr 11, 2018) | |||
13-26214380-T-C | Inborn genetic diseases | Uncertain significance (Jun 22, 2023) | ||
13-26214507-T-C | Inborn genetic diseases | Uncertain significance (Oct 05, 2022) | ||
13-26214521-C-T | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
13-26214554-C-T | Inborn genetic diseases | Uncertain significance (Dec 21, 2022) | ||
13-26214743-T-C | Inborn genetic diseases | Uncertain significance (Jul 13, 2022) | ||
13-26214793-T-C | Benign (Apr 18, 2018) | |||
13-26214861-C-G | Inborn genetic diseases | Uncertain significance (Oct 12, 2021) | ||
13-26214920-G-C | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
13-26214925-A-C | Inborn genetic diseases | Uncertain significance (Mar 14, 2023) | ||
13-26215017-C-T | Inborn genetic diseases | Uncertain significance (May 30, 2023) | ||
13-26215062-G-A | Inborn genetic diseases | Uncertain significance (Jul 13, 2022) | ||
13-26215127-C-T | Inborn genetic diseases | Likely benign (Aug 30, 2021) | ||
13-26215151-C-T | Esophageal squamous cell carcinoma, somatic | Pathogenic (Aug 01, 2002) | ||
13-26215158-C-T | Esophageal squamous cell carcinoma, somatic | Pathogenic (Aug 01, 2002) | ||
13-26215274-A-G | Inborn genetic diseases | Uncertain significance (May 11, 2022) | ||
13-26215290-T-C | Inborn genetic diseases | Uncertain significance (Dec 21, 2022) | ||
13-26215314-T-C | Likely benign (Aug 15, 2018) | |||
13-26215440-G-A | Inborn genetic diseases | Uncertain significance (Dec 15, 2021) | ||
13-26215530-G-A | Inborn genetic diseases | Uncertain significance (Mar 06, 2023) | ||
13-26215577-C-T | Esophageal squamous cell carcinoma, somatic | Pathogenic (Aug 01, 2002) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF6 | protein_coding | protein_coding | ENST00000381588 | 3 | 90539 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0139 | 0.986 | 125727 | 0 | 20 | 125747 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.25 | 310 | 378 | 0.819 | 0.0000219 | 4469 |
Missense in Polyphen | 73 | 110.82 | 0.65875 | 1357 | ||
Synonymous | 0.365 | 125 | 130 | 0.959 | 0.00000649 | 1377 |
Loss of Function | 3.54 | 9 | 29.8 | 0.302 | 0.00000244 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000148 | 0.000148 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000796 | 0.0000791 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase mediating 'Lys-48'-linked polyubiquitination of LIMK1 and its subsequent targeting to the proteasome for degradation. Negatively regulates axonal outgrowth through regulation of the LIMK1 turnover. Mediates 'Lys-6' and 'Lys-27'-linked polyubiquitination of AR/androgen receptor thereby modulating its transcriptional activity. May also bind DNA and function as a transcriptional regulator. {ECO:0000269|PubMed:19345326}.;
- Disease
- DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. {ECO:0000269|PubMed:12154016}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
- Pathway
- Androgen receptor signaling pathway;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;AndrogenReceptor
(Consensus)
Recessive Scores
- pRec
- 0.0930
Intolerance Scores
- loftool
- 0.766
- rvis_EVS
- 0.16
- rvis_percentile_EVS
- 64.85
Haploinsufficiency Scores
- pHI
- 0.118
- hipred
- N
- hipred_score
- 0.344
- ghis
- 0.573
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf6
- Phenotype
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;ubiquitin-dependent protein catabolic process;negative regulation of axon extension;protein K27-linked ubiquitination;positive regulation of transcription, DNA-templated;regulation of androgen receptor signaling pathway;protein K48-linked ubiquitination;protein K6-linked ubiquitination
- Cellular component
- nucleus;nucleoplasm;cytoplasm;PML body;axon;nuclear membrane;intracellular membrane-bounded organelle
- Molecular function
- DNA binding;ubiquitin-protein transferase activity;protein binding;metal ion binding;androgen receptor binding;ubiquitin protein ligase activity